文献速递乳房整形与再造

美国商业保险女性乳腺癌患者的乳房再造

Breast Reconstruction Among Commercially Insured Women With Breast Cancer in the United States.
PubMed 文献 · Ann Plast Surg · 2018-01-01

本研究利用MarketScan商业理赔数据库,纳入2011年7月1日至2014年9月30日期间行乳房切除术的19至64岁乳腺癌女性,评估乳房再造趋势及相关因素。在17,502例患者中,73%接受了乳房再造,其中66%为即刻再造、7%为延迟再造;即刻再造最常用组织扩张器(约77%)。总体再造率从2011年第三季度的69.47%升至2014年第三季度的75.72%。

要点

  • 17,502例乳房切除术患者中,73%(n=12,816)接受了乳房再造。
  • 即刻再造占66%(n=11,613),延迟再造占7%(n=1,203)。
  • 即刻再造最常用组织扩张器(约77%),脱细胞真皮基质使用增加。

核心结论

  • 在商业保险支付环境下,大多数行乳房切除术的女性接受了乳房再造。
  • 在即刻再造女性中,组织扩张器的使用很常见。
  • 多种因素与接受乳房再造的决定相关。

研究设计与样本

  • 利用MarketScan商业理赔与 encounters 数据库识别2011年7月1日至2014年9月30日期间行乳房切除术的19至64岁乳腺癌女性。
  • 以该期间首次手术日期为索引日期,要求索引前后12个月连续参保,并随访索引后12个月。
  • 采用多变量回归分析确定与乳房再造相关的因素。

主要发现

  • 研究期间17,502例行乳房切除术的女性中,73%(n=12,816)接受了乳房再造。
  • 其中66%(n=11,613)为即刻再造,7%(n=1,203)为延迟再造。
  • 总体再造率从2011年第三季度的69.47%上升至2014年第三季度的75.72%。
  • 即刻再造中最常见的类型为使用组织扩张器(伴或不伴假体及自体再造)(约77%),其次为假体再造(9.67%)、自体再造(10.81%)和其他再造(2.52%)。
  • 脱细胞真皮基质常与即刻组织扩张器和即刻假体为基础的再造联合使用,且其使用在研究期间增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study evaluated trends related to breast reconstruction and the factors associated with reconstruction. METHODS: Women with breast cancer aged 19 to 64 years who underwent a mastectomy procedure between July 1, 2011, and September 30, 2014, were identified from the MarketScan Commercial Claims and Encounters Database. The first date of surgical procedure during this period was defined as the index date. Continuous enrollment during the 12-month preindex and postindex period was required, and the patient sample was followed for 12 months postindex. Multivariable regression analysis was used to determine factors associated with having breast reconstruction. RESULTS: Among the 17,502 women undergoing mastectomy during the study period, 73% (n = 12,816) had breast reconstruction, with 66% (n = 11,613) having immediate and 7% (n = 1203) having delayed reconstruction. Overall reconstruction rates increased during the study period from 69.47% in the third quarter of 2011 to 75.72% in the third quarter of 2014. The most common type of immediate reconstruction involved the use of tissue expanders (with or without implant and autologous reconstruction) (~77%), followed by implant reconstruction (9.67%), autologous reconstruction (10.81%), and other reconstruction (2.52%). Acellular dermal matrix was commonly used with immediate tissue expander and immediate implant-based reconstruction, and its use increased during the study period. Demographic and treatment-related factors were found to be associated with reconstruction among women undergoing mastectomy. CONCLUSIONS: In this commercial payor setting, most women undergoing mastectomy had breast reconstruction. Among women undergoing immediate reconstruction, tissue expander use was common. Several factors were shown to be associated with the decision to have breast reconstruction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Barnow A, Canfield T, Liao R, et al. Breast Reconstruction Among Commercially Insured Women With Breast Cancer in the United States. Ann Plast Surg. 2018. PMID: 29781849. doi:10.1097/SAP.0000000000001454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。